MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Psoriasis: Treatment and Pathogenesis
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

2,393 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
2,393 works in the cohort · of 4,299,418page 1 of 48

Labels cover 8 of 2,393 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 2,393 of 2,393 works in this cohort. Predictions are machine_predicted_unvalidated teacher distillation outputs. Candidate is the union; consensus is the intersection.

affunlabeled
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Richard G. Langley, Boni E. Elewski, Mark Lebwohl, Kristian Reich, C.E.M. Griffiths, Kim Papp +14 more
2014· article· en· New England Journal of Medicine· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
1,964
citations
affunlabeled
Brodalumab, an Anti–Interleukin-17–Receptor Antibody for Psoriasis
Kim Papp, Craig L. Leonardi, Alan Menter, Jean‐Paul Ortonne, James G. Krueger, Gregory Kricorian +5 more
2012· article· en· New England Journal of Medicine· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
929
citations
affno abstractunlabeled
Psoriasis
Jacqueline Greb, Ari M. Goldminz, James T. Elder, Mark Lebwohl, Dafna D. Gladman, Jashin J. Wu +3 more
2016· review· en· Nature Reviews Disease Primers· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrow+research_integrity+insufficient_payloadconsensus · insufficient_payload
897
citations
affunlabeled
Efficacy and safety of guselkumab, an anti-interleukin-23 monoclonal antibody, compared with adalimumab for the continuous treatment of patients with moderate to severe psoriasis: Results from the phase III, double-blinded, placebo- and active comparator–controlled VOYAGE 1 trial
Andrew Blauvelt, Kim Papp, C.E.M. Griffiths, B. Randazzo, Yasmine Wasfi, Yaung‐Kaung Shen +2 more
2017· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
860
citations
affunlabeled
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis
Kenneth B. Gordon, Andrew Blauvelt, Kim Papp, Richard G. Langley, Thomas A. Luger, Mamitaro Ohtsuki +14 more
2016· article· en· New England Journal of Medicine· Immunology and Microbiology
distilled prediction:candidate · insufficient_payloadconsensus · none
838
citations
affunlabeled
Apremilast, an oral phosphodiesterase 4 (PDE4) inhibitor, in patients with moderate to severe plaque psoriasis: Results of a phase III, randomized, controlled trial (Efficacy and Safety Trial Evaluating the Effects of Apremilast in Psoriasis [ESTEEM] 1)
Kim Papp, Kristian Reich, Craig L. Leonardi, Leon Kircik, Sergio Chimenti, Richard G. Langley +6 more
2015· article· en· Journal of the American Academy of Dermatology· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
669
citations
affunlabeled
European consensus statement on phenotypes of pustular psoriasis
Alexander A. Navarini, A. David Burden, Francesca Capon, Ulrich Mrowietz, L. Puig, Sulev Kõks +3 more
2017· review· en· Journal of the European Academy of Dermatology and Venereology· Immunology and Microbiology
distilled prediction:candidate · metaepi_narrowconsensus · none
440
citations
affunlabeled
Diagnosis and management of psoriasis.
Whan B. Kim, Dana Jerome, Jensen Yeung
2017· review· en· PubMed· Immunology and Microbiology
distilled prediction:candidate · noneconsensus · none
412
citations

How this was built: Screen · Findings · About